GLP-1 receptor agonists (GLP-1RAs) are a novel class of drugs for T2DM (2); they stimulate insulin secretion, increase β cell mass, and suppress glucagon secretion (3–5). This evidence concerns the gene GLP1R and type 2 diabetes mellitus.